Article: Combination therapy of essential hypertension with pindolol (Visken) and hydralazine

Thirty patients suffering from essential hypertension were treated successively with placebo, hydralazine alone, and pindolol (Visken) combined with hydralazine. Hydralazine caused a statistically significant reduction in blood pressure and an increase in pulse rate as compared with the placebo: palpitations were an irritating side-effect. The combination of hydralazine and pindolol resulted in an additional fall in blood pressure (p less than 0.001) and the pulse rate decreased (2 p less than 0.001). The combined treatment also had a favourable effect on palpitations and angina pectoris.

Citing Articles

Clinical pharmacokinetics of hydrallazine.

Talseth T Clin Pharmacokinet. 1977; 2(5):317-29.

PMID: 913002 DOI: 10.2165/00003088-197702050-00001.

The antihypertensive effect of pindolol (Visken) alone and combined with clopamide (Brinaldix).

Persson I Eur J Clin Pharmacol. 1977; 11(6):419-21.

PMID: 330169 DOI: 10.1007/BF00562931.

The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.

Prichard B Br J Clin Pharmacol. 1978; 5(5):379-99.

PMID: 26370 PMC: 1429347. DOI: 10.1111/j.1365-2125.1978.tb01644.x.

References

1.

Gilmore E, Weil J, CHIDSEY C . Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade. N Engl J Med. 1970; 282(10):521-7. DOI: 10.1056/NEJM197003052821001. View

2.

Prichard B, GILLAM P . Treatment of hypertension with propranolol. Br Med J. 1969; 1(5635):7-16. PMC: 1981816. DOI: 10.1136/bmj.1.5635.7. View

3.

FREIS E, Rose J, Higgins T, Finnerty Jr F, Kelley R, PARTENOPE E . The hemodynamic effects of hypotensive drugs in man. IV. 1-Hydrazinophthalazine. Circulation. 1953; 8(2):199-204. DOI: 10.1161/01.cir.8.2.199. View

4.

Warren D, Swainson C, Wright N . Deterioration in renal function after beta-blockade in patients with chronic renal failure and hypertension. Br Med J. 1974; 2(5912):193-4. PMC: 1610826. DOI: 10.1136/bmj.2.5912.193. View

5.

Gottlieb T, KATZ F, CHIDSEY 3rd C . Combined therapy with vasodilator drugs and beta-adrenergic blockade in hypertension. A comparative study of minoxidil and hydralazine. Circulation. 1972; 45(3):571-82. DOI: 10.1161/01.cir.45.3.571. View

6.

FREIS E . Hemodynamics of hypertension. Physiol Rev. 1960; 40:27-54. DOI: 10.1152/physrev.1960.40.1.27. View

7.

Hansson L, Olander R, Aberg H, MALMCRONA R, Westerlund A . Treatment of hypertension with propranolol and hydralazine. Acta Med Scand. 1971; 190(6):531-4. DOI: 10.1111/j.0954-6820.1971.tb07470.x. View

8.

Shinebourne E, FLEMING J, Hamer J . Effects of beta-adrenergic blockade during exercise in hypertensive and ischaemic heart-disease. Lancet. 1967; 2(7528):1217-20. DOI: 10.1016/s0140-6736(67)90561-2. View

9.

SANNERSTEDT R, Stenberg J, Vedin A, Wilhelmsson C, WERKO L . Chronic beta adrenergic blockade in arterial hypertension. Hemodynamic influences of dihydralazine and dynamic exercise and clinical effects of combined treatment. Am J Cardiol. 1972; 29(5):718-23. DOI: 10.1016/0002-9149(72)90176-2. View

10.

Persson I, Ulrich J . Treatment of hypertension with a new beta-blocking agent, pindolol (Visken). Eur J Clin Pharmacol. 1973; 6(4):217-9. DOI: 10.1007/BF00644734. View

11.

Alarcon-Segovia D, WAKIM K, WORTHINGTON J, WARD L . Clinical and experimental studies on the hydralazine syndrome and its relationship to systemic lupus erythematosus. Medicine (Baltimore). 1967; 46(1):1-33. DOI: 10.1097/00005792-196701000-00001. View

Combination Therapy of Essential Hypertension with Pindolol (Visken) and Hydralazine